MADELYN COUDERC: Open Payments
NPI 1548947245 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 38 payments from 12 companies in 2025. Trend: 2023 $65 · 2024 $891 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $249 |
| UROGEN PHARMA, INC. | 6 | $207 |
| COLOPLAST CORP | 9 | $139 |
| ABBVIE INC. | 4 | $109 |
| Astellas Pharma US Inc | 1 | $98 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| IMMUNITYBIO, INC. | 3 | $73 |
| Boston Scientific Corporation | 2 | $44 |
| PFIZER INC. | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 1 | $27 |
Products named: RYBREVANT, ZUSDURI, Xtandi, Luja Coude, BOTOX, GEMTESA, ANKTIVA, ERLEADA.
Industry payments across CA — which companies pay providers there.
